Thursday’s Highlights at Noon: La Jolla Pharma (LJPC), Freeport-McMoRan (FCX), The ExOne Company (XONE), National-Oilwell (NOV), Bluebird Bio (BLUE)

So far Thursday, October 24, NASDAQ is up 0.5% and the S&P is down -1.11%. Here are this morning’s most active stocks: La Jolla Pharma (LJPCResearch Report), Freeport-McMoRan (FCXResearch Report), The ExOne Company (XONEResearch Report), National-Oilwell (NOVResearch Report) and Bluebird Bio (BLUEResearch Report).

La Jolla Pharma is down -5.97% in midday trading to $7.88. Shares opened today at $8.38. The company has a 52-week low of $5.01 and a 52-week high of $18.04. On the Street’s front, the average 12-month analyst price target for the stock is $26.00, marking a 210.26% potential upside from current levels. In a report issued on August 29, H.C. Wainwright analyst Edward White maintained a Buy rating on LJPC, with a price target of $27.00, which implies an upside of 222% from current levels.

Freeport-McMoRan is down -5.39% in midday trading to $9.57. Shares opened today at $10.11. The company has a 52-week low of $8.43 and a 52-week high of $14.68. On the Street’s front, the average 12-month analyst price target for the stock is $12.67, marking a 25.32% potential upside from current levels. In a report released today, BMO analyst David Gagliano maintained a Hold rating on FCX, with a price target of $12.00, which represents a potential upside of 19% from where the stock is currently trading. Separately, on the same day, B.Riley FBR’s Lucas Pipes reiterated a Buy rating on the stock and has a price target of $13.00. In the last 30 days, insiders purchased $53.75K worth of FCX shares.

The ExOne Company is down -5.39% in midday trading to $6.84. Shares opened today at $7.23. The company has a 52-week low of $5.73 and a 52-week high of $11.73. On the Street’s front, the average 12-month analyst price target for the stock is $12.00, marking a 65.98% potential upside from current levels. In a report issued on September 16, B.Riley FBR analyst Christopher Van Horn initiated coverage with a Buy rating on XONE and a price target of $12.00, which represents a potential upside of 66% from where the stock is currently trading.

See today’s analyst top recommended stocks >>

National-Oilwell is down -5.28% in midday trading to $20.53. Shares opened today at $21.67. The company has a 52-week low of $18.05 and a 52-week high of $38.05. On the Street’s front, the average 12-month analyst price target for the stock is $26.00, marking a 19.98% potential upside from current levels. In a report issued on October 8, Morgan Stanley analyst Connor Lynagh maintained a Hold rating on NOV, with a price target of $25.00, which represents a potential upside of 15% from where the stock is currently trading. Separately, on October 1, Citigroup’s Scott Gruber maintained a Buy rating on the stock and has a price target of $27.00. In the last 30 days, insiders purchased $26.25K worth of NOV shares. Over the last 3 months, the insider sentiment on National-Oilwell has been negative based on 34 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.

See today’s analyst top recommended stocks >>

Bluebird Bio is down -5.19% in midday trading to $81.43. Shares opened today at $85.89. The company has a 52-week low of $80.81 and a 52-week high of $163.43. On the Street’s front, the average 12-month analyst price target for the stock is $158.00, marking a 83.96% potential upside from current levels. In a report issued on October 11, Morgan Stanley analyst Matthew Harrison maintained a Hold rating on BLUE, with a price target of $104.00, which represents a potential upside of 21% from where the stock is currently trading. Separately, on August 13, Evercore ISI’s Joshua Schimmer maintained a Buy rating on the stock and has a price target of $172.00.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.